Detalhe da pesquisa
1.
PD-L1-PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection.
Nat Immunol
; 23(5): 743-756, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35437326
2.
Author Correction: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.
Nat Immunol
; 20(11): 1556, 2019 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-31582823
3.
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.
Nat Immunol
; 20(3): 326-336, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30778252
4.
B-cell-specific checkpoint molecules that regulate anti-tumour immunity.
Nature
; 619(7969): 348-356, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37344597
5.
Prognostic significance of cutaneous immune-related adverse events in patients with melanoma and other cancers on immune checkpoint inhibitors.
J Am Acad Dermatol
; 86(4): 886-889, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33722547
6.
The double-edged sword: Harnessing PD-1 blockade in tumor and autoimmunity.
Sci Immunol
; 6(65): eabf4034, 2021 Nov 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34739340
7.
Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer.
JAMA Dermatol
; 157(5): 577-582, 2021 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33760001
8.
Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment.
J Exp Med
; 218(4)2021 04 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33651880
9.
PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance.
J Exp Med
; 218(1)2021 01 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33045061